Novo Nordisk A S (ADR) (NVO) Analysts See $0.56 EPS; Eagle Bancorp Montana (EBMT)’s Sentiment Is 2.6

August 8, 2017 - By Adrian Mccoy

Analysts expect Novo Nordisk A S (ADR) (NYSE:NVO) to report $0.56 EPS on August, 9 before the open.They anticipate $0.04 EPS change or 6.67% from last quarter’s $0.6 EPS. NVO’s profit would be $1.10B giving it 18.60 P/E if the $0.56 EPS is correct. After having $0.58 EPS previously, Novo Nordisk A S (ADR)’s analysts see -3.45% EPS growth. The stock decreased 0.95% or $0.4 on August 7, reaching $41.66. About shares traded. Novo Nordisk A S (ADR) (NYSE:NVO) has declined 23.93% since August 8, 2016 and is downtrending. It has underperformed by 40.63% the S&P500.

Eagle Bancorp Montana, Inc. is the bank holding firm for Opportunity Bank of Montana . The company has market cap of $69.75 million. The Bank is a Montana-chartered commercial bank. It has a 14.04 P/E ratio. The Bank has equity investments in Certified Development Entities, which have received allocations of New Markets Tax Credits (NMTC).

Glacier Peak Capital Llc holds 4.46% of its portfolio in Eagle Bancorp Montana Inc for 367,768 shares. Oppenheimer & Close Llc owns 112,250 shares or 2.13% of their US portfolio. Moreover, Minerva Advisors Llc has 0.3% invested in the company for 25,598 shares. The Florida-based Naples Global Advisors Llc has invested 0.16% in the stock. Deprince Race & Zollo Inc, a Florida-based fund reported 199,932 shares.

The stock increased 0.27% or $0.05 on August 7, reaching $18.3. About shares traded. Eagle Bancorp Montana Inc (EBMT) has risen 42.05% since August 8, 2016 and is uptrending. It has outperformed by 25.35% the S&P500.

Novo Nordisk A/S is a global healthcare firm engaged in diabetes care. The company has market cap of $81.89 billion. The Firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It has a 17.19 P/E ratio. The Firm operates through two business divisions: diabetes and obesity care, and biopharmaceuticals.